126 related articles for article (PubMed ID: 14129631)
1. CONGENITAL ERYTHROBLASTIC HYPOPLASIA; TREATMENT OF TRANSFUSION HEMOSIDEROSIS WITH DESFERRIOXAMINE B.
HILDNER FJ; MONTO RW; REBUCK JW
Henry Ford Hosp Med Bull; 1964 Mar; 12():5-13. PubMed ID: 14129631
[No Abstract] [Full Text] [Related]
2. Congenital erythroblastic hypoplasia. Treatment of transfusion hemosiderosis with desferrioxamine B.
Hildner FJ; Monto RW; Rebuck JW
Henry Ford Hosp Med J; 1968; 16(2):147-55. PubMed ID: 5650037
[No Abstract] [Full Text] [Related]
3. THE TREATMENT OF IRON OVERLOAD WITH DESFERRIOXAMINE B.
NORMAN CS
Ir J Med Sci; 1964 Jan; 457():13-8. PubMed ID: 14113899
[No Abstract] [Full Text] [Related]
4. [TREATMENT OF IRON LOADING WITH DESFERRIOXAMINE].
DE VRIES SI; GOUDSMIT R; SCHRETLEN ED; VAN MUNSTERP
Ned Tijdschr Geneeskd; 1963 Oct; 107():1796-800. PubMed ID: 14095450
[No Abstract] [Full Text] [Related]
5. [The effect of desferrioxamine on the treatment of transfusion hemosiderosis--with special reference to the method of its administration (authors' transl)].
Fujiyama N; Nakazawa K
Rinsho Ketsueki; 1977 Dec; 18(12):1393-400. PubMed ID: 604522
[No Abstract] [Full Text] [Related]
6. [CONGENITAL HYPOPLASTIC ANEMIA. REVIEW AND REPORT ON A CASE TREATED WITH DESFERRIOXAMINE B].
KARSTOFT H
Ugeskr Laeger; 1964 Jul; 126():929-33. PubMed ID: 14176761
[No Abstract] [Full Text] [Related]
7. [Subcutaneous administration of deferoxamine in a patient with panmyelopathy and post-transfusion hemosiderosis].
Zdziarska B; Urasiński I
Pol Arch Med Wewn; 1987 Jul; 78(1):48-51. PubMed ID: 3271285
[No Abstract] [Full Text] [Related]
8. [Current status of treatments with desferrioxamine B in post-transfusion hypersiderosis in children].
Orsini A; Raybaud C; Bernard PJ; Aquaron R; Passeron P
Mars Med; 1967; 104(4):331-7. PubMed ID: 5621537
[No Abstract] [Full Text] [Related]
9. [A NEW TEST FOR ASCERTAINMENT OF STATES OF SIDEROSIS: THE DESFERRIOXAMINE TEST. PRELIMINARY RESULTS].
SCURO LA; BROCCIA G; DOBRILLA G; TAGLIAMONTE A
Policlinico Prat; 1964 Jul; 71():1101-13. PubMed ID: 14174378
[No Abstract] [Full Text] [Related]
10. THE TREATMENT OF HAEMOCHROMATOSIS WITH DESFERRIOXAMINE.
WOEHLER F
Acta Haematol; 1963 Aug; 30():65-87. PubMed ID: 14064792
[No Abstract] [Full Text] [Related]
11. [THE USE OF DESFERRIOXAMINE IN THE TREATMENT OF HEMOCHROMATOSIS].
CARLOS AG; SOARES AD
J Med (Oporto); 1964 Apr; 53():1021-32. PubMed ID: 14145895
[No Abstract] [Full Text] [Related]
12. [Transfusion induced hypersiderosis in aplastic anemia--physiopathology and therapeutic aspects].
Andres J
Z Gesamte Inn Med; 1983 Feb; 38(3):81-3. PubMed ID: 6845780
[TBL] [Abstract][Full Text] [Related]
13. [Effect of continuous subcutaneous infusion of deferoxamine in a boy with congenital hypoplastic anemia].
Ishitoya N; Gomibuchi I; Fujisawa K; Akatsuka J
Rinsho Ketsueki; 1988 Sep; 29(9):1408-12. PubMed ID: 3216512
[No Abstract] [Full Text] [Related]
14. [Long-term study in congenital refractory anemia and secondary siderosis].
Tuschy U; Schmidt U; Meinhold J; Wutke K
Z Gesamte Inn Med; 1982 Apr; 37(7):213-7. PubMed ID: 7102009
[TBL] [Abstract][Full Text] [Related]
15. [Results obtained in the treatment of post-transfusional hemosiderosis with desferrioxamine ina case of hypoplastic congenital anemia of the Joseph-Blackfan-Diamon type].
Nicolini A; Marca L; Pani C
Minerva Pediatr; 1967 Aug; 19(34):1590-2. PubMed ID: 5610735
[No Abstract] [Full Text] [Related]
16. Transfusion hemosiderosis. Report of a case treated with desferrioxamine-B.
Kaung DT
J Iowa Med Soc; 1965 Jun; 55(6):312-6. PubMed ID: 5835475
[No Abstract] [Full Text] [Related]
17. [Post-transfusion hemosiderosis in the course of chronic anemia due to multiple transfusions (444 blood transfusions in 10 years)].
PEDOYA C; MOLINIER A; DUCHESNE G; AZORIN D
Bull Mem Soc Med Hop Paris; 1956 Mar 9-23; 72(9-11):304-12. PubMed ID: 13316502
[No Abstract] [Full Text] [Related]
18. [Hemosiderosis and hemochromatosis].
VAN RIJSSEL TG; STENFERT KROESE WF
Ned Tijdschr Geneeskd; 1951 Dec; 95(51):3843-52. PubMed ID: 14919725
[No Abstract] [Full Text] [Related]
19. Effect of subcutaneous deferoxamine and oral vitamin C on iron excretion in congenital hypoplastic anemia and refractory anemia associated with the 5q-syndrome.
Ambruso DR; Mahony BS; Githens JH; Rhoades ED
Am J Pediatr Hematol Oncol; 1982; 4(2):115-23. PubMed ID: 7114394
[TBL] [Abstract][Full Text] [Related]
20. Continuous high-dose intravenous desferrioxamine treatment for iron overload.
Sidi Y; Shaklai M; Liban E; Pinkhas J
Isr J Med Sci; 1981 May; 17(5):348-51. PubMed ID: 7263191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
